Valuation: Grand Pharmaceutical Group Limited

Market Cap 18.49B 2.36B 2.02B 1.89B 1.73B 3.26B 225B 3.3B 22.34B 8.7B 113B 8.86B 8.66B 376B P/E 2026 *
9.78x
P/E 2027 * 8.84x
Enterprise Value 18.49B 2.36B 2.02B 1.89B 1.73B 3.26B 225B 3.3B 22.34B 8.7B 113B 8.86B 8.66B 376B EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.25x
Free-Float
34.99%
Yield 2026 *
4.55%
Yield 2027 * 5.3%
1 day+1.14%
1 week+1.52%
Current month+3.49%
1 month+3.69%
3 months-2.20%
6 months-31.10%
Current year-31.97%
1 week 5.16
Extreme 5.16
5.72
1 month 5.01
Extreme 5.01
5.72
Current year 4.53
Extreme 4.53
8.18
1 year 4.53
Extreme 4.53
9.66
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 31/05/2021
Corporate Secretary 57 31/08/2011
Director TitleAgeSince
Director/Board Member 63 20/03/2005
Director/Board Member 66 11/05/2011
Director/Board Member 62 30/12/2018
Date Insider Type Main position Quantity % Market Cap.
22/08/25 Other

Chief Executive Officer

45,500 0.0013%
17/06/25 Other

Chairman

50,000 0.0014%
20/05/25 Other

Chief Executive Officer

24,500 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+1.52%-44.20%+29.30% 2.36B
-1.06%+0.65%+77.42%+122.82% 1,100B
+0.53%+0.75%+53.10%+64.29% 658B
+0.48%+2.65%+28.06%+81.19% 470B
+0.92%+3.57%+43.82%+44.21% 372B
+1.25%+2.21%+26.77%+43.05% 304B
+3.02%+5.68%+4.24%+17.04% 264B
-0.36%+3.99%+53.31%+72.49% 239B
+2.86%+3.86%-16.20%-51.83% 213B
+1.38%+3.72%+30.33%+93.56% 184B
Average +1.02%+2.49%+25.66%+51.61% 380.52B
Weighted average by Cap. +0.45%+2.21%+45.62%+71.79%

Financials

2026 *2027 *
Net sales 13.34B 1.7B 1.46B 1.37B 1.25B 2.36B 162B 2.38B 16.12B 6.27B 81.85B 6.39B 6.25B 271B 14.78B 1.89B 1.62B 1.51B 1.38B 2.61B 180B 2.64B 17.86B 6.95B 90.69B 7.08B 6.93B 300B
Net income 1.91B 244M 209M 196M 179M 338M 23.26B 341M 2.31B 900M 11.74B 916M 896M 38.87B 2.09B 266M 228M 214M 195M 368M 25.37B 372M 2.52B 981M 12.8B 999M 977M 42.39B
Net Debt - -
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,614
Date Price Change Volume
26/08/26 HK$5.340 +1.14% 2,022,000
25/08/26 HK$5.280 +0.96% 5,389,500
24/08/26 HK$5.230 -0.48% 4,389,500
21/08/26 HK$5.255 -4.11% 9,317,000
20/08/26 HK$5.480 +4.18% 18,552,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.280HKD
Average target price
11.90HKD
Spread / Average Target
+125.38%

Annual profits - Rate of surprise